Aptose Biosciences
APTO
#10564
Rank
โ‚ฌ3.76 M
Marketcap
1,48ย โ‚ฌ
Share price
0.00%
Change (1 day)
-46.00%
Change (1 year)

Earnings for Aptose Biosciences (APTO)

Earnings in 2025 (TTM): -โ‚ฌ19.25 Million

According to Aptose Biosciences's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ21.76 Million, an increase over its 2023 earnings that were of -โ‚ฌ45.17 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aptose Biosciences from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ19.25 Million-11.53%
2024 -โ‚ฌ21.76 Million-51.82%
2023 -โ‚ฌ45.17 Million22.9%
2022 -โ‚ฌ36.76 Million-34.91%
2021 -โ‚ฌ56.47 Million17.36%
2020 -โ‚ฌ48.12 Million107.65%
2019 -โ‚ฌ23.17 Million-7.73%
2018 -โ‚ฌ25.12 Million160.68%
2017 -โ‚ฌ9.64 Million-20.27%
2016 -โ‚ฌ12.09 Million28.71%
2015 -โ‚ฌ9.39 Million
2013 -โ‚ฌ5.33 Million
2010 -โ‚ฌ4.54 Million-8.31%
2009 -โ‚ฌ4.95 Million
2006 -โ‚ฌ9.17 Million-156.93%
2005 โ‚ฌ16.09 M-185.16%
2004 -โ‚ฌ18.91 Million458.58%
2003 -โ‚ฌ3.39 Million-63.66%
2002 -โ‚ฌ9.32 Million-8.04%
2001 -โ‚ฌ10.13 Million16.73%
2000 -โ‚ฌ8.68 Million294.99%
1999 -โ‚ฌ2.2 Million-6.51%
1998 -โ‚ฌ2.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ImmunoGen
IMGN
-โ‚ฌ54.16 Million 200.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
-โ‚ฌ58.25 Million 222.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-โ‚ฌ29.36 Million 62.62%๐Ÿ‡บ๐Ÿ‡ธ USA